Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant proteins for genetic disease.

C S Russell1, L A Clarke

  • 1Department of Medical Genetics, University of British Columbia, British Columbia Research Institute for Children's and Women's Health, Vancouver, Canada.

Clinical Genetics
|August 18, 1999
PubMed
Summary

Recombinant proteins offer a near-term therapeutic impact for genetic disorders, serving as a proof of principle for future gene therapies. Advances in protein engineering promise novel treatments for inherited diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The therapist who is perceived as "spiritually correct": strategies for avoiding collusion with the "spiritually one-up" spouse.

Journal of marital and family therapy·2010
Same author

The action of adrenaline on the excised human uterus; with a short additional note on the action of quinine.

The Journal of obstetrics and gynaecology of the British Empire·2010
Same author

Errors in the routine daily measurement of the puerperal uterus.

Biometrika·2010
Same author

Human fertility.

Lancet (London, England)·2010
Same author

Enucleation of Six Ovarian Dermoids from One Woman, with Conservation of Ovaries.

British medical journal·2010
Same author

Maternal mortality, stillbirths and neo-natal deaths.

Nursing mirror and midwives journal·2010

Area of Science:

  • Molecular Biology
  • Biotechnology
  • Genetics

Background:

  • Molecular biology advancements provide tools for genetic disorder therapeutics.
  • Recombinant proteins are poised to significantly impact genetic disease treatment in the short term.
  • Current gene therapy emphasis is noted, but protein-based approaches offer immediate potential.

Purpose of the Study:

  • To review advances in using recombinant proteins for genetic diseases.
  • To highlight the future potential of recombinant protein therapeutics.
  • To underscore the role of protein replacement as a precursor to gene therapy.

Main Methods:

  • Review of clinical evaluations of recombinant proteins.
  • Analysis of enzyme replacement therapies for genetic disorders.

Related Experiment Videos

  • Discussion of protein engineering and novel protein functions.

    • Main Results:

    • Recombinant proteins, like adenosine deaminase and glucocerebrosidase, show success in treating genetic disorders (SCID, Gaucher disease).
    • Clinical trials of enzyme replacement therapies validate protein-based treatments and drive gene therapy development.
    • Protein engineering is creating novel therapeutic agents, including fusion proteins.

    Conclusions:

    • Recombinant proteins are effective therapeutics for genetic disorders and serve as a proof of concept for gene-based therapies.
    • The 'molecularization of medicine' enhances understanding of disease pathogenesis.
    • Widespread use of recombinant proteins will be facilitated by improved availability and delivery systems.